|
|
Aptalis Pharma Begins Promotion of RECTIV™ to Physicians in the U.S.
|
Adverse Reporting
To report suspected Adverse Reactions, contact Aptalis Pharma at 1-800-472-2634 or the FDA at 1-800-FDA-1088
Customer Service:
(800) 472-2634 (U.S.) and
(800) 809-4950 (Canada)
Aptalis Pharma™ Launches PYLERA® in France: A Therapeutic Alternative for Eradicating Helicobacter Pylori and Preventing Relapse of H. Pylori Associated Peptic Ulcers
BRIDGEWATER, NJ--(Marketwired - Apr 11, 2013) - Aptalis Pharma, US Inc. announced that its French sister company, Aptalis Pharma SAS, has launched PYLERA® to healthcare professionals in France...
